openPR Logo
Press release

Recombinant Therapeutic Antibodies & Proteins Market Set for Rapid Growth and Trend by 2023

01-18-2018 03:11 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Recombinant Therapeutic Antibodies & Proteins Market Set

Increasing investment on research activities and introduction of new protein therapeutics has significantly contributed in growth and development of Recombinant Therapeutic Antibodies and Proteins Market. Moreover rising number of clinical trials in pharmaceutical industry have also contributed in growth and development of market in past few years. Owing to increased focus on developing innovative monoclonal antibodies (mAb), this segment is expected to dominate during the forecast period. Interestingly, although the recombinant therapeutic and proteins market is significantly smaller than overall pharmaceutical market yet the growth rate of the market is significantly higher than the overall pharmaceutical market.

Restraint to the growth of the market includes lack of variety in formulations as most the recombinant antibodies and proteins can only be administered via injections. There are several problems associated with the administration of protein drug via injection such as it increases the overall cost of the treatment, need of trained caregiver during the course of treatment barring a few such as insulin and others. Additionally patent expiration of branded drugs and budget constraints are another major factor limiting the growth and exploration of application areas.

Request Brochure of The Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7310

Geographically the market is largely dominated by the developed economic regions such as North America and Europe owing to rapid growth of the biotechnology derived techniques in these two regions. Additionally significant research support in terms of infrastructure and funding has also driven recombinant therapeutic antibodies and proteins market in past one decade. Emerging markets such as Asia Pacific and Rest of the World market are expected to be the fastest growing market pertaining to developing economic scenario and increasing demand for therapeutics market. Owing to such reforms and growth in developing economic countries have successfully contributed in attracting prominent players to these regions as a strategy to increase customer base and business expansion.

Major branded monoclonal antibodies in the market include Rituxan (rituxumab), Synagis (Palivizumab), Campath (Alemtuzumab), Erbitux (Cetuximab). Whereas branded therapeutic proteins in the market comprises Levemir (Datemir insulin), Neulasta (PEG-Filgrastim), Enbrel (Etanercept), Ontak (rIL2-diptheria toxin) and others. Recombinant proteins currently in clinical trial phase include AERAS-404, Interferon alpha2a Fusion Protein, Anakinra, Aldesleukin and others.

Some of the prominent players operating in the global recombinant therapeutic antibodies and protein market include Bristol-Myers Squibb, Celldex Therapeutics, Inc., Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., Novartis International AG, Schering AG, Johnson & Johnson and others.

Request Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=7310

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recombinant Therapeutic Antibodies & Proteins Market Set for Rapid Growth and Trend by 2023 here

News-ID: 907574 • Views: 192

More Releases from Transparency Market Research

Distributed Operating System Market: A Latest Research Report to Share Industry …
A distributed operating system is a software which is a collection of distinct computational nodes that are networked, independent, and communicating in order to perform certain operations The distributed operating system manages the jobs that are serviced by multiple processing units. Every distinct node holds a precise software subset of the global collective operating system. Each subset is a composite of two distinct service provisions. The first subset is a universal kernel,
Research Outlines Huge Growth In Automatic Dependent Surveillance Broadcast Mark …
Automatic dependent surveillance-broadcast (ADS-B) is surveillance technology which enables an aircraft to determine its position through satellite navigation. Automatic dependent surveillance-broadcast (ADS-B) helps to track an aircraft through periodical broadcasts. As a replacement for secondary surveillance radar, automatic dependent surveillance - broadcast (ADS–B) technology can be used by air traffic control ground stations to gather information regarding tracking of the aircraft. It can also be used by other aircrafts to enable
RF Shielded Test Enclosures Market: Structure and Overview of Key Industry
RF shielded test enclosures, also called RF shielded test boxes, are used for testing of RF and microwave devices in an isolated test environment, which lacks interference of other devices as well as the external environment These test boxes are used in isolation from unintended electromagnetic interference in noisy surroundings. In order to check whether a device is functioning up to the mark in an isolated environment, these boxes are used
Pitot Tube Anemometers Market Will Escalate Rapidly in the Near Future
A pitot tube anemometer is a flow measurement device that is designed to measure and display air pressure, air velocity, volumetric flow, and air temperature Pitot tube anemometers involve use of the microprocessor technology for signal processing, which ensures quick and accurate measuring results Pitot tube anemometers are available in two types i.e. portable and fixed When not in use, a pitot tube anemometer should be placed in dry conditions and be protected

All 5 Releases


More Releases for Recombinant

Global Recombinant Factor VIII Market Research Report
This report studies the global Recombinant Factor VIII market status and forecast, categorizes the global Recombinant Factor VIII market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Shire (Baxter) Bayer CSL Pfizer Biogen Octapharma NovoNordisk Geographically, this report studies the top producers
United States Recombinant Vaccine Market Report
In this report, the United States Recombinant Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
Recombinant DNA Technology Market -
Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have
Global Human Recombinant Insulin Market – Industry Insights
Discovery of insulin is considered to be one of the most important events in the history of the diabetes treatment. Furthermore, major advances in human insulin technology is the synthesis of human insulin analogue by recombinant technology. Currently, human insulin delivery system available for the administration of insulin include insulin syringes, insulin pumps, jet injections, and pens. Key players are focused on developing recombinant human insulin instead of animal-based insulin,
Global Human Recombinant Insulin Market – Industry Insights
Various government and private research organizations are engaged research and development activities for developing advanced treatment in diabetes care to increase the effectiveness of human insulin, reduce diabetes burden, and minimize the risk of diabetes associated disorders such as diabetes-associated blindness, kidney disease, heart attacks, strokes or limb loss. For instance, American Diabetes Association (ADA) invested US$ 807.4 million in more than 4,700 research projects in diabetes research since 1952
Recombinant Vaccines Market Industry Forecast till 2025
Recombinant vaccines are produced by using recombinant DNA technology or genetic engineering for the prevention of lethal diseases in human beings and animals. Recombinant vaccine is a biological preparation that provides active acquired immunity against a certain disease. Whereas individual being vaccinated produces antibodies against the protein antigen that protect a person from contracting the disease upon attack from the pathogenic microorganism. These vaccines functions on the immune response for